Cancer vaccine

Cervical cancer vaccine postponed again

Vaccination against cervical cancer has been postponed again to allow for one more appeal against the county council's public procurement process, Swedish News Agency TT reports.

In October Girls in grades five and six were supposed to receive the vaccine, which protects against the sexually transmitted human papillomavirus (HPV), a leading cause of cervical cancer.

Glaxo Smith Kline, one of the pharmaceutical companies competing in the tender with its Cervarix HPV vaccine, appealed the county's decision to award the contract to Sanofi Pasteur MSD's Gardasil vaccine.

This marks the second appeal of the tender.

The Swedish Association of Local Authorities and Regions (SALAR) recently announced that the tender was done and that vaccination against HPV would start in October.